Literature DB >> 17210725

The terminology issue for myeloid-derived suppressor cells.

Dmitry I Gabrilovich, Vincenzo Bronte, Shu-Hsia Chen, Mario P Colombo, Augusto Ochoa, Suzanne Ostrand-Rosenberg, Hans Schreiber.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17210725      PMCID： PMC1941787          DOI： 10.1158/0008-5472.CAN-06-3037

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  6 in total

1.  CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells.

Authors:  Rongcun Yang; Zhong Cai; Yuan Zhang; William H Yutzy; Katherine F Roby; Richard B S Roden
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

2.  Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion.

Authors:  Arnold H Zea; Paulo C Rodriguez; Michael B Atkins; Claudia Hernandez; Sabina Signoretti; Jovanny Zabaleta; David McDermott; David Quiceno; Amanda Youmans; Anne O'Neill; James Mier; Augusto C Ochoa
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

3.  All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.

Authors:  Noweeda Mirza; Mayer Fishman; Ingo Fricke; Mary Dunn; Anthony M Neuger; Timothy J Frost; Richard M Lush; Scott Antonia; Dmitry I Gabrilovich
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

4.  Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host.

Authors:  Bo Huang; Ping-Ying Pan; Qingsheng Li; Alice I Sato; David E Levy; Jonathan Bromberg; Celia M Divino; Shu-Hsia Chen
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

5.  Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis.

Authors:  Pratima Sinha; Virginia K Clements; Suzanne Ostrand-Rosenberg
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

6.  Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway.

Authors:  Yulia Nefedova; Srinivas Nagaraj; Amsler Rosenbauer; Carlos Muro-Cacho; Said M Sebti; Dmitry I Gabrilovich
Journal:  Cancer Res       Date:  2005-10-15       Impact factor: 12.701
  6 in total
  301 in total

Review 1.  Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils.

Authors:  Stephen J Galli; Niels Borregaard; Thomas A Wynn
Journal:  Nat Immunol       Date:  2011-10-19       Impact factor: 25.606

Review 2.  Myeloid-derived suppressor cells in transplantation and cancer.

Authors:  Jordi C Ochando; Shu Hsia Chen
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

3.  Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species.

Authors:  Robert S Tacke; Hai-Chon Lee; Celeste Goh; Jeremy Courtney; Stephen J Polyak; Hugo R Rosen; Young S Hahn
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

Review 4.  Neutrophils in the Tumor Microenvironment.

Authors:  Davalyn R Powell; Anna Huttenlocher
Journal:  Trends Immunol       Date:  2015-12-14       Impact factor: 16.687

5.  A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapy.

Authors:  Brynn B Duncan; Steven L Highfill; Haiying Qin; Najat Bouchkouj; Shannon Larabee; Peng Zhao; Iwona Woznica; Yuxin Liu; Youhua Li; Wengen Wu; Jack H Lai; Barry Jones; Crystal L Mackall; William W Bachovchin; Terry J Fry
Journal:  J Immunother       Date:  2013-10       Impact factor: 4.456

6.  Endoplasmic reticulum stress induced LOX-1+  CD15+ polymorphonuclear myeloid-derived suppressor cells in hepatocellular carcinoma.

Authors:  Jiang Nan; Yan-Fang Xing; Bo Hu; Jian-Xin Tang; Hui-Min Dong; Yu-Mei He; Dan-Yun Ruan; Qing-Jian Ye; Jia-Rong Cai; Xiao-Kun Ma; Jie Chen; Xiu-Rong Cai; Ze-Xiao Lin; Xiang-Yuan Wu; Xing Li
Journal:  Immunology       Date:  2017-12-21       Impact factor: 7.397

Review 7.  Altered macrophage differentiation and immune dysfunction in tumor development.

Authors:  Antonio Sica; Vincenzo Bronte
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 8.  Harnessing the immune system to treat cancer.

Authors:  Nina Bhardwaj
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

9.  Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism.

Authors:  Lyse A Norian; Paulo C Rodriguez; Leigh A O'Mara; Jovanny Zabaleta; Augusto C Ochoa; Marina Cella; Paul M Allen
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

10.  Invariant natural killer T cells regulate breast cancer response to radiation and CTLA-4 blockade.

Authors:  Karsten A Pilones; Noriko Kawashima; Anne Marie Yang; James S Babb; Silvia C Formenti; Sandra Demaria
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.